Acuvi Ab Stock Price To Earnings To Growth
| ACUVI Stock | 15.80 0.20 1.28% |
Acuvi AB fundamentals help investors to digest information that contributes to Acuvi AB's financial success or failures. It also enables traders to predict the movement of Acuvi Stock. The fundamental analysis module provides a way to measure Acuvi AB's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Acuvi AB stock.
Acuvi |
Acuvi AB Company Price To Earnings To Growth Analysis
Acuvi AB's PEG Ratio indicates the potential value of an equity instrument and is calculated by dividing Price to Earnings (P/E) ratio into earnings growth rate. Most analysts and investors prefer this measure to a Price to Earnings (P/E) ratio because it incorporates the future growth of a firm. The low PEG ratio usually implies that an equity instrument is undervalued; whereas PEG of 1 may indicate that an equity is reasonably priced under given expectations of future growth.
Generally speaking, PEG ratio is a 'quick and dirty' way to measure how the current price of a firm's stock relates to its earnings and growth rate. The main benefit of using PEG ratio is that investors can compare the relative valuations of companies within different industries without analyzing their P/E ratios.
| Competition |
Based on the latest financial disclosure, Acuvi AB has a Price To Earnings To Growth of 0.0 times. This is 100.0% lower than that of the Technology sector and 100.0% lower than that of the Electronic Components industry. The price to earnings to growth for all Sweden stocks is 100.0% higher than that of the company.
Did you try this?
Run Equity Valuation Now
Equity ValuationCheck real value of public entities based on technical and fundamental data |
| All Next | Launch Module |
Acuvi Fundamentals
| Return On Equity | -0.24 | |||
| Return On Asset | -0.19 | |||
| Profit Margin | (0.43) % | |||
| Operating Margin | (0.71) % | |||
| Current Valuation | 518.09 M | |||
| Shares Outstanding | 25.52 M | |||
| Shares Owned By Insiders | 28.48 % | |||
| Shares Owned By Institutions | 15.71 % | |||
| Price To Book | 1.30 X | |||
| Price To Sales | 3.23 X | |||
| Revenue | 154.7 M | |||
| Gross Profit | (9.49 M) | |||
| EBITDA | (33.24 M) | |||
| Book Value Per Share | 15.30 X | |||
| Earnings Per Share | (3.37) X | |||
| Target Price | 56.0 | |||
| Number Of Employees | 58 | |||
| Beta | 0.79 | |||
| Market Capitalization | 458.83 M |
About Acuvi AB Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Acuvi AB's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Acuvi AB using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Acuvi AB based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Acuvi Stock Analysis
When running Acuvi AB's price analysis, check to measure Acuvi AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Acuvi AB is operating at the current time. Most of Acuvi AB's value examination focuses on studying past and present price action to predict the probability of Acuvi AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Acuvi AB's price. Additionally, you may evaluate how the addition of Acuvi AB to your portfolios can decrease your overall portfolio volatility.